In 2025, Novo Nordisk completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Novo Nordisk has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Location-Based | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Unspecified Calculation Method | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novo Nordisk’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions of Novo Nordisk amounted to 318,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Novo Nordisk increased by 22.78%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2025, the total Scope 1 emissions of Novo Nordisk were 120,000 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Novo Nordisk's Scope 1 emissions have increased by 39.53%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2024), Novo Nordisk's Scope 1 emissions increased by 41.18%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Novo Nordisk reported Scope 2 greenhouse gas (GHG) emissions of 63,000 tCO₂e using the market-based method and 198,000 tCO₂e using the location-based method.a
Compared to the previous year (2024), Novo Nordisk's Scope 2 emissions (Location-Based) rose by 13.79% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2025, Novo Nordisk reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Novo Nordisk reported 2,507,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Novo Nordisk includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Novo Nordisk reported total Scope 3 emissions of 2,507,000 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 99.88% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.12% came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2019, Novo Nordisk's Scope 3 emissions have increased by 1,628.97%, reflecting a rising long-term trend in Scope 3 emissions over time.ab
Compared to the previous year (2024), Novo Nordisk's Scope 3 emissions increased by 16.06%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2025, Novo Nordisk reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2025, the largest contributors to Novo Nordisk's Scope 3 emissions were:a
In 2025, Novo Nordisk reported Scope 1 greenhouse gas (GHG) emissions of 120,000 tCO₂e and total revenues of USD 48,646 millions. This translates into an emissions intensity of 2.47 tCO₂e per millions USD.a
In 2025, Novo Nordisk reported a Scope 1 emissions intensity of 2.47 tCO₂e per millions USD. Compared to the peer group median of 7.2, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Novo Nordisk ranked 4 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Novo Nordisk among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2025, Novo Nordisk reported a total carbon footprint of 2,825,000 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 16.78% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Novo Nordisk's total carbon footprint was Scope 3 emissions, accounting for 88.74% of the company's total carbon footprint, followed by Scope 2 emissions at 7.01%.a